J&J’s EGFR-mutated advanced lung cancer treatment: amivantamab-vmjw plus lazertinib gains FDA…
The chemotherapy-free regimen showed progression-free survival versus osimertinib
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
lung cancer treatment
US FDA approves AstraZeneca’s non-small cell lung cancer treatment
Imfinzi gains expanded use, and AstraZeneca’s shares rise after a priority review for small cell lung cancer
New phase-III data support Roche’s Tecentriq in early-stage lung cancer
As published in The Lancet, Tecentriq is the first and only cancer immunotherapy to demonstrate positive phase-III results in the…
Mirati drug combination shrinks tumours in 39 per cent of colon cancer patients in study
Adagrasib targets a mutated form of a gene known as KRAS that occurs in around 13 per cent of non-small cell lung cancers, three…